Jian Liu

Jian Liu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Health Data Science
Verified
Journal Article
Open access
QZQinghao Zhao
Qinghao Zhao
SGShijia Geng
Shijia Geng
BWBoya Wang
Boya Wang
YSYutong Sun
Yutong Sun
WNWenchang Nie
Wenchang Nie
SHShenda Hong
Shenda Hong
Importance: Heart sound auscultation is a routinely used physical examination in clinical practice to identify potential cardiac abnormalities. However, accurate interpretation of heart sounds requires specialized training and experience, which limits its generalizability. Deep learning, a subset of machine learning, involves training artificial neural networks to learn from large datasets and perform complex tasks with intricate patterns. Over the past decade, deep learning has been successfully applied to heart sound analysis, achieving remarkable results and accumulating substantial heart sound data for model training. Although several reviews have summarized deep learning algorithms for heart sound analysis, there is a lack of comprehensive summaries regarding the available heart sound data and the clinical applications. Highlights: This review will compile the commonly used heart sound datasets, introduce the fundamentals and state-of-the-art techniques in heart sound analysis and deep learning, and summarize the current applications of deep learning for heart sound analysis, along with their limitations and areas for future improvement. Conclusions: The integration of deep learning into heart sound analysis represents a significant advancement in clinical practice. The growing availability of heart sound datasets and the continuous development of deep learning techniques contribute to the improvement and broader clinical adoption of these models. However, ongoing research is needed to address existing challenges and refine these technologies for broader clinical use.

1 October 2020 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
RZRui Zhang
Rui Zhang
CSChenxi Song
Chenxi Song
CGChangdong Guan
Changdong Guan
QLQianqian Liu
Qianqian Liu
CWChunyue Wang
Chunyue Wang
BXBo Xu
Bo Xu
Background: The potential impact of quantitative flow ratio (QFR) based functional Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) score (FSS QFR ) on prognostication and revascularization strategy choice has not been fully investigated, and the discriminant ability of FSS QFR needs further validation. Methods: QFR was retrospectively analyzed in left main or patients with multivessel coronary artery disease from the PANDA III trial. A total of 607 patients with analyzable QFR in all vessels were included. FSS QFR was counted by summing the individual scores only in ischemia-producing lesions (vessel QFR ≤0.8). Patients were stratified according to tertiles of SYNTAX score (SS), and 3 groups of FSS were divided by the same cutoff score. The primary end point was 2-year major adverse cardiac events (a composite of cardiac death, any myocardial infarction, or ischemia-driven revascularization). Results: After calculating the FSS QFR , 16% (96/607) of study patients moved from higher-risk group by SS to lower-risk group. In the low, intermediate, and high FSS QFR group, the cumulative incidence of 2-year major adverse cardiac events was 9.1%, 13.5%, and 22.3% ( P =0.0004), and the rate of a composite of cardiac death or myocardial infarction (3.8%, 7.3%, and 13.7%, P =0.0006) was also increased. Compared with SS, FSS QFR significantly improved risk classification and prognostication (area under the curve of the receiver-operating characteristics 0.65 versus 0.62, P =0.0009). Moreover, 6% (38/607) of patients, for whom coronary artery bypass grafting would be recommended according to SS, converted to favor percutaneous coronary intervention after FSS QFR calculation. After multivariate adjustment, FSS QFR was an independent predictor of 2-year major adverse cardiac events (adjusted hazard ratio, 1.05 [95% CI, 1.02–1.07]; P =0.0001). Conclusions: Among patients with left main or multivessel coronary artery disease, FSS QFR showed applicability in prognostication and revascularization strategy choice. An improved scoring system combining anatomy and physiology (FSS QFR ) discriminated the risk of adverse events modestly better than anatomic assessment (SS) alone. Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02017275. Graphic A graphic abstract is available for this article.

10 March 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
MMMinglu Ma
Minglu Ma
CHChang Hou
Chang Hou
JLJian Liu
Jian Liu
Atherosclerosis is a basic pathological characteristic of many cardiovascular diseases, and if not effectively treated, patients with such disease may progress to atherosclerotic cardiovascular diseases (ASCVDs) and even heart failure. The level of plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) is significantly higher in patients with ASCVDs than in the healthy population, suggesting that it may be a promising new target for the treatment of ASCVDs. PCSK9 produced by the liver and released into circulation inhibits the clearance of plasma low-density lipoprotein-cholesterol (LDL-C), mainly by downregulating the level of LDL-C receptor (LDLR) on the surface of hepatocytes, leading to upregulated LDL-C in plasma. Numerous studies have revealed that PCSK9 may cause poor prognosis of ASCVDs by activating the inflammatory response and promoting the process of thrombosis and cell death independent of its lipid-regulatory function, yet the underlying mechanisms still need to be further clarified. In patients with ASCVDs who are intolerant to statins or whose plasma LDL-C levels fail to descend to the target value after treatment with high-dose statins, PCSK9 inhibitors often improve their clinical outcomes. Here, we summarize the biological characteristics and functional mechanisms of PCSK9, highlighting its immunoregulatory function. We also discuss the effects of PCSK9 on common ASCVDs.

1 March 2018 in Thrombosis Research
Verified
Journal Article
Closed access
XNXiao-yan Nie
Xiao-yan Nie
JLJun-Lei Li
Jun-Lei Li
SQSi-Bei Qin
Si-Bei Qin
YFYu Fu
Yu Fu
GLGuang-Kai Liang
Guang-Kai Liang
YLYun Lu
Yun Lu

15 May 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
YFYundi Feng
Yundi Feng
XWXuan Wang
Xuan Wang
TFTingting Fan
Tingting Fan
LLLi Li
Li Li
XSXiaotong Sun
Xiaotong Sun
YHYunlong Huo
Yunlong Huo
Background: Microvascular bifurcation asymmetry is of significance for regulation of coronary flow heterogeneity during juvenile and adult growth. The aim of the study is to investigate the morphometric and hemodynamic variation of coronary arterial bifurcations in mice of different ages. Methods: Pulsatile blood flows were computed from a Womersley-type model in the reconstructed left coronary arterial (LCA) trees from Micro-CT images in normal mice at ages of 3 weeks, 6 weeks, 12 weeks, 5-6 months, and >8 months. Diameter and flow ratios and bifurcation angles were determined in each bifurcation of the LCA trees. Results: The blood volume and inlet flow rate of LCA trees increase and decrease during juvenile and adult growth, respectively. As vessel diameters decrease, the increased ratios of small to large daughter vessel diameters (D_s/D_m) result in more uniform flows and lower velocities. There are significant structure-functional changes of LCA trees in mice of >8 months compared with mice of <8 months. As D_s/D_m increases, the variation trend of bifurcation angle during juvenile growth is different from that during adult growth. Conclusions: Although inlet flows are different in adult vs juvenile mice, the adult still have uniform flow and low velocity. This is accomplished through a decrease in diameter. The design ensures ordered dispersion of red cells through asymmetric branching patterns into the capillaries.

1 September 2021 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
JLJincheng Liu
Jincheng Liu
BMBoyan Mao
Boyan Mao
YFYue Feng
Yue Feng
BLBao Li
Bao Li
JLJian Liu
Jian Liu
YLYoujun Liu
Youjun Liu